DocGo Inc. - DCGO STOCK NEWS

DocGo Inc. has secured two new mobile health contracts in Nevada, valued at approximately $55 million over three years. These contracts will facilitate COVID-19 testing, vaccination programs, and at-home monoclonal antibody infusion treatments. With over 2 million COVID tests and vaccinations conducted to date, DocGo is expanding its services significantly, emphasizing their commitment to accessible healthcare. The company operates across 28 states and aims to extend its monoclonal antibody infusion program to additional U.S. markets shortly.

DocGo has launched a new website aimed at enhancing its brand identity and growth as a leading provider of mobile health services. This redesign showcases the company's mission of delivering healthcare directly to patients through innovative mobile solutions. With a focus on accessibility and affordability, the website reflects DocGo's commitment to improving healthcare delivery. The site features engaging design elements and represents its transformation into a technology-driven healthcare innovator. DocGo continues to expand its impact on the healthcare landscape through integrated mobile solutions.

DocGo, a leading provider of mobile health services, has launched DocGo Academy and DocGo EMS Academy, programs aimed at recruiting and training healthcare professionals amid a nationwide worker shortage. The initiatives offer free tuition for employees who remain with DocGo, combining classroom education with practical training. This strategic move not only enhances workforce capabilities but also addresses the urgent need for healthcare staff during challenging times. Plans for nationwide expansion are underway, promoting accessibility to healthcare careers.

DocGo, a leader in mobile health services, will participate in Capstone's Annual Future of Healthcare Policy Virtual Summit on December 8. President Anthony Capone will join a panel discussing the healthcare labor force challenges stemming from the pandemic, including the impact of COVID-19 and vaccine mandates. The summit aims to connect D.C. policy issues with corporate implications, featuring industry leaders and policymakers analyzing key healthcare topics. DocGo continues to innovate in healthcare delivery through its AI-powered solutions, enhancing patient access and care efficiency.

DocGo has increased its full-year 2021 revenue guidance to between $290 million and $300 million, up from $260 million. This rise is attributed to higher Mobile Health revenues, driven by extensions of key contracts and recent wins. Adjusted EBITDA is now projected at least $12 million, up from $10 million. The company continues to expand its mobile health services across 28 states and the UK, with licenses pending in an additional 21 states, positioning itself for growth in 2022 and beyond.

DocGo has appointed Aaron Severs as Chief Product Officer, aiming to enhance its technology and software offerings. Severs brings extensive experience from Mindbody and has a history of leading SaaS products. The company plans to leverage his expertise to expand its mobile health services into the B2C market, catering to the growing demand for accessible healthcare. With HealthPoint's 800,000 registered users, DocGo seeks to improve health outcomes through technology-driven solutions. The move aligns with industry trends favoring telemedicine and consumer-friendly healthcare delivery.

DocGo reported a remarkable 219% year-over-year revenue increase for Q3 2021, reaching $85.8 million, driven by $67.9 million from Mobile Health. The net income turned positive at $0.8 million compared to a loss of $2.7 million in Q3 2020. With a year-to-date revenue of $197.4 million, also a 214% increase, the company is witnessing significant growth post-merger with Motion Acquisition Corp. The adjusted EBITDA for Q3 was $4.0 million, marking a strong turnaround.